Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2014 May;95(5):723-731.
doi: 10.1189/jlb.1213633. Epub 2014 Feb 21.

Th17 cells and Tregs: unlikely allies

Affiliations
Review

Th17 cells and Tregs: unlikely allies

Xin Chen et al. J Leukoc Biol. 2014 May.

Abstract

Identification of CD4+Foxp3+ Tregs and Th17 modified the historical Th1-Th2 paradigm. Currently, the Th17-Tregs dichotomy provides a dominant conceptual framework for the comprehension of immunity/inflammation and tolerance/immunosuppression in an increasing number of diseases. Targeting proinflammatory Th17 cells or immunosuppressive Tregs has been widely considered as a promising therapeutic strategy in the treatment of major human diseases, including autoimmunity and cancer. The efficacy and safety of such therapy rely on a thorough understanding of immunobiology and interaction of these two subsets of Th cells. In this article, we review recent progress concerning complicated interplay of Th17 cells and Tregs There is compelling evidence that Tregs potently inhibit Th1 and Th2 responses; however, the inhibitory effect of Tregs on Th17 responses is a controversial subject. There is increasing evidence showing that Tregs actually promote the differentiation of Th17 cells in vitro and in vivo and consequently, enhanced the functional consequences of Th17 cells, including the protective effect in host defense, as well as detrimental effect in inflammation and in the support of tumor growth. On the other hand, Th17 cells were also the most potent Th subset in the stimulation and support of expansion and phenotypic stability of Tregs in vivo. These results indicate that these two subsets of Th cells reciprocally stimulate each other. This bidirectional crosstalk is largely dependent on the TNF-TNFR2 pathway. These mutual stimulatory effects should be considered in devising future Th17 cell- and Treg-targeting therapy.

Keywords: Foxp3; IL-17; TNF; TNFR2; immunosuppression; inflammation.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.. Reciprocal stimulation of Tregs and Th17 cells.
Tregs are able to promote the differentiation and function of Th17 cells, through a mechanism involving the supply of TGF-β, which is required for Th17 differentiation, or inhibition of Th1 and Th2 cytokines and IL-2, which are known to block Th17 differentiation. Induced and natural Th17 cells also stimulate the activation and expansion and promote Foxp3 expression of Tregs by producing TNF, IL-2, or other mediators required for the survival and activation of Tregs. Therefore, the immunosuppressive Tregs and proinflammatory Th17 cells reciprocally stimulate and temper each other, resulting in a dynamic equilibrium in an ongoing immune/inflammatory response.

Similar articles

Cited by

References

    1. Zhu J., Yamane H., Paul W. E. (2010) Differentiation of effector CD4 T cell populations (*). Annu. Rev. Immunol. 28, 445–489 - PMC - PubMed
    1. Mosmann T. R., Cherwinski H., Bond M. W., Giedlin M. A., Coffman R. L. (1986) Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. J. Immunol. 136, 2348–2357 - PubMed
    1. Sakaguchi S., Yamaguchi T., Nomura T., Ono M. (2008) Regulatory T cells and immune tolerance. Cell 133, 775–787 - PubMed
    1. Belkaid Y., Rouse B. T. (2005) Natural regulatory T cells in infectious disease. Nat. Immunol. 6, 353–360 - PubMed
    1. Kryczek I., Wei S., Zou L., Altuwaijri S., Szeliga W., Kolls J., Chang A., Zou W. (2007) Cutting edge: Th17 and regulatory T cell dynamics and the regulation by IL-2 in the tumor microenvironment. J. Immunol. 178, 6730–6733 - PubMed

Publication types

MeSH terms

Substances